Aflac Gestion
Gestion contrôle des critères 2/4
Le PDG Aflac est Dan Amos, nommé en Jan1990, a un mandat de 36.33 ans. La rémunération annuelle totale est $ 25.03M, composée du salaire de 5.8% et des bonus 94.2%, y compris les actions et options de la société. détient directement 0.57% des actions de la société, d'une valeur de $ 340.53M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 4.8 ans et 9.3 ans.
Informations clés
Dan Amos
Directeur général
US$25.0m
Rémunération totale
| Pourcentage du salaire du PDG | 5.76% |
| Durée du mandat du directeur général | 36.3yrs |
| Propriété du PDG | 0.6% |
| Durée moyenne d'occupation des postes de direction | 4.8yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 9.3yrs |
Mises à jour récentes de la gestion
Recent updates
Seeking Alpha • May 06
Aflac: An Insurer To Buy After Impressive Q1 Results, Even As Valuation Rises
Summary Aflac remains a Buy despite a Q1 earnings miss, supported by organic policy growth, proven dividend increases, and robust balance sheet strength. Growth catalysts include new policy sales, expanding Asian market presence, and niche segments like pet insurance, though revenue trends remain uneven. Margins and expense ratios are favorable, with A-level credit ratings and conservative leverage, but forward P/E multiples signal some overvaluation and more muted near-term upside. Dividend growth (+16% YoY) and a low payout ratio (~30%) reinforce AFL's appeal for income investors, while technicals support a bullish trend as well after a recovery signal. Read the full article on Seeking Alpha
Mise à jour du récit • May 01
AFL: Future Returns Will Balance Reinsurance Moves With Cautious Earnings Expectations
Narrative Update on Aflac The consensus analyst price target for Aflac has edged lower by a few dollars to $111.86, as analysts factor in more cautious revenue growth assumptions alongside slightly stronger profit margin and future P/E inputs. Analyst Commentary Recent research on Aflac reflects a mixed but mostly cautious tone, with several firms trimming price targets by small amounts and one lifting its target and reinitiating coverage at a neutral stance.Mise à jour du récit • Apr 17
AFL: Future Returns Will Reflect Mixed Earnings Outlook And Product Expansion
Aflac's updated fair value estimate has been trimmed from $113 to about $111.86 as analysts consolidate mixed price target moves. This reflects slightly softer assumptions on revenue growth, profit margins, and future P/E while still seeing support from recent target adjustments across major firms.Mise à jour du récit • Apr 03
AFL: Future Returns Will Reflect Capital Strength And Earnings Execution Risks
Narrative Update The analyst price target framework for Aflac now centers around $113. This reflects updated Street work, with some firms raising targets toward $118 and others trimming into the $101 to $120 range as analysts refresh earnings estimates and extend their valuation horizons.Mise à jour du récit • Mar 20
AFL: Future Returns Will Balance Cybersecurity Fallout And Capital Strength
Narrative update on Aflac The analyst price target framework for Aflac shifts modestly higher toward the recent Street range, reflecting updated EPS roll forward work, a slightly adjusted future P/E assumption to 16.36x, and analysts' mixed but constructive views that blend a higher $118 target with several reductions closer to $101 to $120. Analyst Commentary Recent research on Aflac is mixed, with some bullish analysts nudging targets higher while more cautious voices trim expectations.Mise à jour du récit • Mar 05
AFL: Future Returns Will Weigh Cyber Breach Risks Against Capital Strength
Aflac's updated analyst price target edges higher to about $113, supported by analysts rolling their models to 2027 and 2028 EPS and fine tuning assumptions around slightly stronger profit margins and a modestly lower future P/E multiple. Analyst Commentary Recent Street research on Aflac highlights a mix of optimism and caution as analysts update their models and valuation frameworks out to 2027 and 2028.Mise à jour du récit • Feb 19
AFL: Future Returns Will Balance Cyber Risk And Capital Strength
Analysts now see Aflac's fair value edging up by $1 to $111.69 per share, reflecting adjusted price targets that factor in updated views on revenue growth, profit margins, and future P/E multiples. Analyst Commentary Bullish and cautious voices are both active around Aflac right now, with recent price target trims reflecting fine tuning of expectations rather than a wholesale shift in views on execution or valuation.Mise à jour du récit • Feb 05
AFL: Future Returns Will Reflect Capital Strength Versus Cyber And Insurance Headwinds
Narrative Update: Aflac The analyst price target for Aflac has been trimmed slightly, with a new fair value estimate of about $110.69 compared with $110.85 before. Analysts are factoring in updated sector views on life and P&C insurers, modest tweaks to revenue growth and margin assumptions, and only a small adjustment to future P/E expectations.Article d’analyse • Jan 30
Aflac's (NYSE:AFL) Dividend Will Be Increased To $0.61
Aflac Incorporated ( NYSE:AFL ) has announced that it will be increasing its dividend from last year's comparable...Mise à jour du récit • Jan 21
AFL: Future Returns Will Balance Capital Strength With Cyber And Sector Headwinds
Narrative Update on Aflac Aflac's updated analyst price target edges lower to about $111, as analysts moderate expectations for revenue growth and margins while still citing capital strength, cash flow, and sector consolidation as key supports. Analyst Commentary Recent research on Aflac reflects a mix of optimism about capital strength and cash flow, alongside caution around industry headwinds and valuation expectations.Mise à jour du récit • Jan 06
AFL: Future Returns Will Reflect Stable Earnings Power And Capital Returns Balancing Cyber Risks
Analysts made only a small adjustment to their Aflac fair value estimate, with the target price moving from about $111.08 to $111.31 as they factor in recent price target revisions across the sector, softer pricing trends in some insurance lines, and generally steady modeling updates following calm recent earnings seasons. Analyst Commentary Street research around Aflac reflects a mix of optimism on company specific execution and caution around broader insurance pricing trends, which feeds into relatively modest adjustments to fair value estimates.Mise à jour du récit • Dec 15
AFL: Future Performance Will Reflect Claims Tailwinds And Balanced Capital Return Execution
Analysts have modestly raised their price targets on Aflac, with recent upward revisions ranging from approximately $5 to $6 per share. They cite better than expected life insurance earnings, favorable claims experience, and resilient earnings trends despite macro uncertainties.Mise à jour du récit • Dec 01
AFL: Future Performance Will Reflect Strength In Claims And Distribution Execution
Aflac's analyst price target increased modestly, with recent updates reflecting improved life insurance earnings and stable macro conditions as key factors cited by analysts. Analyst Commentary Recent updates from street research highlight several factors influencing Aflac's valuation targets, with analysts weighing both potential growth drivers and areas of caution.Article d’analyse • Nov 18
Aflac's (NYSE:AFL) Dividend Will Be $0.58
The board of Aflac Incorporated ( NYSE:AFL ) has announced that it will pay a dividend on the 1st of December, with...Mise à jour du récit • Nov 16
AFL: Future Earnings Outlook Will Reflect Improving Claims And Distribution Strength
The analyst price target for Aflac has increased modestly, with a $1 uptick in fair value to $111.00. Analysts point to stable industry conditions and improving claims experience supporting the outlook.Mise à jour du récit • Nov 01
AFL: Earnings Stability And Strong Buybacks Will Support Balanced Outlook
Analysts have increased their price targets for Aflac, with upward revisions ranging from $1 to $6 per share. They cite stable earnings performance, as well as positive impacts from new product sales and favorable claims experience.Mise à jour du récit • Oct 18
Custom Cancer Insurance And Digital Underwriting Will Drive Future Expansion
Aflac's analyst price target has been increased from $108.31 to $110.00. Analysts cite steady improvements in revenue growth, profit margins, and favorable claims experience as key factors supporting the upward revision.Mise à jour du récit • Oct 04
Custom Cancer Insurance And Digital Underwriting Will Drive Future Expansion
Aflac's analyst price target has been raised slightly, with an increase of $2 to $108. Analysts highlight strong Q2 sales driven by new product rollouts and improved net interest income.Seeking Alpha • Jan 08
Aflac's Shares Are Overvalued
Summary Aflac Incorporated's heavy reliance on Japan, a market with weak long-term growth prospects, leads to relatively muted growth and significant currency risk exposure. Despite its strong financial position, Aflac's premium valuation compared to peers is unjustified given its average earnings momentum and low dividend yield. Aflac's strategy focuses on attracting younger customers in Japan but faces structural challenges due to the country's aging and shrinking population. For long-term investors, Manulife offers a better risk-reward proposition in the insurance sector compared to Aflac. Read the full article on Seeking AlphaSeeking Alpha • Nov 02
Insurer Aflac Quacks Away At Policy Growth And Low Debt Risk
Summary Aflac gets upgraded to Buy from my prior hold rating a year ago, driven by policy growth & retention in Q3 despite net earnings loss. Although the stock trades near a 10-year-high, it is still undervalued to key peers in terms of fwd P/E and trailing P/B ratios. A trend of dividend growth looks to continue its sustainability. The firm has low debt-to-equity vs peers, with strong credit ratings. Despite a large size of the market, Aflac is in a competitive industry with several large insurance brands to compete with. Read the full article on Seeking AlphaSeeking Alpha • Aug 26
Aflac: Double Digit Dividend Growth And Strong Portfolio Of Investments
Summary Aflac (AFL) has demonstrated financial strength through its increased revenue, net investment gains, and decreased benefits and claims. The current dividend yield remains modest at 1.8% but the dividend growth rate sits in the double digits. This is accompanied by an extremely health payout ratio. AFL's portfolio of debt investments, including middle market loans and commercial real estate, has helped generate higher revenues, but vulnerability exists with potential interest rate cuts and poor credit ratings. Read the full article on Seeking AlphaSeeking Alpha • Apr 22
Aflac Incorporated: Good Positioning But Risks From Japan
Summary Aflac recently reached its all-time high price, but has been showing signs of uncertainty lately. The company possesses a strong business foundation, poised to sustain a steady level of revenue in the foreseeable future, but exposure to macroeconomic scenarios creates uncertainty. I think it would be wise to hold off for now and monitor how the company adapts to the macroeconomic environment. There’s a chance we could buy in at a lower price later on. Read the full article on Seeking AlphaSeeking Alpha • Apr 09
Aflac: Growing Cancer Cases Will Lead To Higher Revenues
Summary Aflac remains a strong dividend-growth company, with a history of increasing dividends for 41 consecutive years. Cancer insurance sales are expected to be a major catalyst for long-term growth in both the Japanese and US markets. Despite missing revenue expectations in the latest earnings report, AFL's financials and outlook remain positive, with a focus on reducing expenses and increasing margins to mitigate short-term decreases. The dividend has grown at a double-digit CAGR over the last five-year period. Read the full article on Seeking AlphaAnalyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | US$5b |
| Dec 31 2025 | US$25m | US$1m | US$4b |
| Sep 30 2025 | n/a | n/a | US$4b |
| Jun 30 2025 | n/a | n/a | US$2b |
| Mar 31 2025 | n/a | n/a | US$4b |
| Dec 31 2024 | US$19m | US$1m | US$5b |
| Sep 30 2024 | n/a | n/a | US$4b |
| Jun 30 2024 | n/a | n/a | US$5b |
| Mar 31 2024 | n/a | n/a | US$5b |
| Dec 31 2023 | US$21m | US$1m | US$5b |
| Sep 30 2023 | n/a | n/a | US$5b |
| Jun 30 2023 | n/a | n/a | US$5b |
| Mar 31 2023 | n/a | n/a | US$5b |
| Dec 31 2022 | US$16m | US$1m | US$4b |
| Sep 30 2022 | n/a | n/a | US$5b |
| Jun 30 2022 | n/a | n/a | US$4b |
| Mar 31 2022 | n/a | n/a | US$4b |
| Dec 31 2021 | US$16m | US$1m | US$4b |
| Sep 30 2021 | n/a | n/a | US$4b |
| Jun 30 2021 | n/a | n/a | US$6b |
| Mar 31 2021 | n/a | n/a | US$6b |
| Dec 31 2020 | US$23m | US$1m | US$5b |
| Sep 30 2020 | n/a | n/a | US$5b |
| Jun 30 2020 | n/a | n/a | US$3b |
| Mar 31 2020 | n/a | n/a | US$3b |
| Dec 31 2019 | US$14m | US$1m | US$3b |
Rémunération vs marché: La rémunération totale de Dan ($USD 25.03M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 14.80M ).
Rémunération et revenus: La rémunération de Dan a augmenté de plus de 20 % au cours de l'année écoulée.
PDG
Dan Amos (73 yo)
36.3yrs
Titularisation
US$25,033,687
Compensation
Mr. Daniel Paul Amos, also known as Dan, has been President since January 1, 2024 and also the Chief Executive Officer of Aflac Incorporated and Aflac since 1990. He has been Chairman of Aflac Incorporated...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Chairman & CEO | 36.3yrs | US$25.03m | 0.57% $ 340.5m | |
| President | 1.3yrs | US$6.87m | 0.0075% $ 4.4m | |
| Senior EVP & CFO | 6.3yrs | US$7.64m | 0.029% $ 17.3m | |
| Executive VP & Global Chief Investment Officer | 3.3yrs | US$6.81m | 0.0069% $ 4.1m | |
| Senior EVP | 12yrs | US$6.01m | 0.054% $ 32.3m | |
| Senior VP of Financial Services & Chief Accounting Officer | 2.3yrs | pas de données | 0.0013% $ 799.5k | |
| Vice President of Capital Markets | no data | pas de données | pas de données | |
| Senior VP & Counsel of Federal Relations | no data | pas de données | pas de données | |
| Executive VP & CFO of Aflac Life Insurance Japan | 7yrs | pas de données | 0.0080% $ 4.7m | |
| Senior VP & Chief Information Security Officer | 10.3yrs | pas de données | pas de données | |
| Senior Vice President of National Account Business Development & Growth Solutions | 1.5yrs | pas de données | pas de données | |
| Senior Vice President of Aflac Dental & Vision | 1.3yrs | pas de données | pas de données |
4.8yrs
Durée moyenne de l'emploi
59.5yo
Âge moyen
Gestion expérimentée: L'équipe de direction de AFL est considérée comme expérimentée (ancienneté moyenne 4.8 ans).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Chairman & CEO | 43.3yrs | US$25.03m | 0.57% $ 340.5m | |
| President of Aflac International & Chairman of Aflac Life Insurance Japan | 17.9yrs | US$3.96m | 0.010% $ 6.1m | |
| President & Representative Director of Aflac Life Insurance Japan | no data | US$3.60m | 0.017% $ 10.1m | |
| Independent Lead Non-Management Director | 13yrs | US$405.13k | 0.015% $ 8.9m | |
| Independent Director | 11.3yrs | US$340.09k | 0.0026% $ 1.6m | |
| Independent Director | 8.5yrs | US$340.09k | 0.0045% $ 2.7m | |
| Independent Director | 9.3yrs | US$365.09k | 0.0099% $ 5.9m | |
| Independent Director | 4yrs | US$340.09k | 0.0012% $ 727.9k | |
| Independent Director | 7yrs | US$330.09k | 0.0041% $ 2.5m | |
| Independent Director | 11yrs | US$355.09k | 0.0050% $ 3.0m | |
| Independent Director | 6yrs | US$315.09k | 0.0029% $ 1.7m | |
| Independent Director | 3yrs | US$315.09k | 0.0015% $ 906.9k |
9.3yrs
Durée moyenne de l'emploi
65.5yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de AFL sont considérés comme expérimentés (ancienneté moyenne 9.3 ans).
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/21 21:45 |
| Cours de l'action en fin de journée | 2026/05/21 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/12/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Aflac Incorporated est couverte par 30 analystes. 9 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Taylor Scott | Barclays |
| Jay Gelb | Barclays |
| Jack Matten | BMO Capital Markets Equity Research |